Evidence map›Paper›PMID 34440046›Full record

ArticleBiology2021

Breast Cancer Mortality in the Americas and Australasia over the Period 1980-2017 with Predictions for 2025.

Cezary Wojtyla, Paola Bertuccio, Michal Ciebiera, Carlo La Vecchia

Abstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cezary WojtylaInternational Prevention Research Institute-Collaborating Centre, Calisia University, 16 Kaszubska St., 62-800 Kalisz, Poland.ORCID 0000-0002-1249-1893
Paola BertuccioDepartment of Biomedical and Clinical Sciences "L. Sacco", Università degli Studi di Milano, Via Giovanni Battista Grassi 74, 20157 Milan, Italy.
Michal CiebieraSecond Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, 80 Ceglowska St., 01-809 Warsaw, Poland.ORCID 0000-0001-5780-5983
Carlo La VecchiaDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Vanzetti 5, 20133 Milan, Italy.ORCID 0000-0003-1441-897X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Substantial progress has been made in the diagnosis, management, and treatment of breast cancer over the last decades. This has affected mortality rates but has also led to inequality in epidemiological trends between different regions of the world. We extracted death certification data for breast cancer from the World Health Organization database. We analyzed trends in breast cancer mortality in selected countries from America, Asia, and Oceania over the 1980-2017 period and predicted numbers of deaths and rates for 2025. In North America, we observed decreased breast cancer mortality, reaching a rate of about 13/100,000 women in 2017. In Latin American countries, breast cancer mortality rates did not consistently decrease. The highest decreases in mortality were observed in Australia. Mortality trends in Asian countries remained among the lowest globally. We have predicted decreased mortality from breast cancer in 2025 for most of the analyzed countries. The epidemiological situation regarding breast cancer mortality is expected to change in the coming years. Advancements in diagnosis and treatment of breast cancer must be extended in various areas of the world to obtain global control of breast cancer mortality.

Indexed as

breast cancermortalityprojectionstrends

Identifiers

PMID34440046
PMCPMC8389642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.